164 completed, 11 terminated, 7 active not recruiting, 5 unknown. 95 Phase 2, 79 Phase 3, 26 Phase 1, 8 Not applicable.
Follow Radiation Therapy Oncology Group: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer Pre & Post Surveys, Opt Out of Questionnaire - Breast Cancer, Prostate Cancer | Recruiting | University of Oklahoma | 420 | 2025-10-16 | 2025-12-17 | |
| Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer Three-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy - Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma | Phase 2 / Phase 3 | Completed | NRG Oncology | 418 | 2015-12-22 | 2026-07-10 |
| A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification Temozolomide, Depatuxizumab mafodotin, Radiation - Glioblastoma, Gliosarcoma | Phase 3 | Completed | AbbVie | 691 | 2015-01-04 | 2023-05-11 |
| Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer Carboplatin, Cisplatin, Durvalumab - Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 | Phase 3 | Active not recruiting | Radiation Therapy Oncology Group | 330 | 2014-01-03 | 2026-06-08 |
| Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer therapeutic conventional surgery, intensity-modulated radiation therapy, cisplatin - Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Oropharynx | Phase 2 | Withdrawn | Radiation Therapy Oncology Group | 2013-12-01 | 2015-03-20 | |
| Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck Soy isoflavone, Radiation, Cisplatin - Cancer of Head and Neck | Phase 1 | Completed | Emory University | 24 | 2013-11-01 | 2019-12-06 |
| Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery regional nodal XRT, chestwall XRT, WBI - Stage IB Breast Cancer, Stage II Breast Cancer | Not applicable | Active not recruiting | NSABP Foundation Inc | 1636 | 2013-08-01 | 2023-12-27 |
| High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery low intensity radiation therapy, Capecitabine, Gemcitabine - Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer | Phase 2 | Terminated | Radiation Therapy Oncology Group | 20 | 2013-08-01 | 2018-07-13 |
| Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer Sorafenib, stereotactic body radiation therapy - Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer | Phase 3 | Completed | Radiation Therapy Oncology Group | 193 | 2013-04-01 | 2026-01-28 |
| TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. IMRT, Cisplatin, placebo - Non-HPV Locally Advanced Head and Neck Cancer | Phase 2 | Completed | Radiation Therapy Oncology Group | 142 | 2013-03-15 | 2023-10-17 |
| Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma bevacizumab, radiation therapy - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Completed | Radiation Therapy Oncology Group | 182 | 2012-12-20 | 2022-12-29 |
| Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC Stereotactic Body Radiation Therapy (SBRT), Surgery - Non-small Cell Lung Cancer | Phase 2 | Unknown | Radiation Therapy Oncology Group | 44 | 2012-12-01 | 2025-01-06 |
| Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Standard radiation therapy, intensity-modulated radiation therapy - Cervical Cancer, Endometrial Cancer | Phase 3 | Completed | Radiation Therapy Oncology Group | 289 | 2012-11-01 | 2022-06-15 |
| Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy Prostate Cancer | Completed | UNC Lineberger Comprehensive Cancer Center | 101 | 2012-06-01 | 2018-08-14 | |
| Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer GnRH agonist, Anti-androgen, TAK-700 - Prostate Cancer | Phase 3 | Completed | Radiation Therapy Oncology Group | 239 | 2012-05-01 | 2026-03-06 |
| Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer Manuka honey in liquid form, Manuka honey in lozenge form, Standard supportive care - Dysphagia, Lung Cancer | Phase 2 | Completed | Radiation Therapy Oncology Group | 163 | 2012-02-01 | 2017-08-31 |
| Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas ganitumab, capecitabine, gemcitabine hydrochloride - Pancreatic Cancer | Phase 1 | Completed | Radiation Therapy Oncology Group | 8 | 2012-02-01 | 2015-11-17 |
| A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors Cisplatin: 40 mg/m2 weekly during radiation, Radiation: 60-66 Gy in 2 Gy daily fractions - Malignant Salivary Gland Tumors | Phase 2 | Completed | King Faisal Specialist Hospital & Research Center | 120 | 2011-11-01 | 2016-02-25 |
| Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery cognitive assessment, magnetic resonance imaging, laboratory biomarker analysis - Adult Diffuse Astrocytoma, Adult Mixed Glioma | Completed | Radiation Therapy Oncology Group | 82 | 2011-10-01 | 2015-03-18 | |
| Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma Rituximab, Cytarabine, Methotrexate - Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects | Phase 2 | Completed | Radiation Therapy Oncology Group | 91 | 2011-09-01 | 2023-07-20 |
Showing 20 of 191. Sign in to see all of them.
Prostatic Neoplasms (34) · Lung Neoplasms (31) · Carcinoma, Non-Small-Cell Lung (29) · Head and Neck Neoplasms (28) · Squamous Cell Carcinoma of Head and Neck (23) · Glioblastoma (19) · Central Nervous System Neoplasms (17) · Gliosarcoma (16) · Radiation Injuries (15) · Brain Neoplasms (12) · Breast Neoplasms (12) · Neoplasm Metastasis (12) · Adenocarcinoma of Lung (10) · Astrocytoma (7) · Glioma (7)
Radiotherapy (91) · Cisplatin (49) · Paclitaxel (27) · Radiotherapy, Intensity-Modulated (26) · Radiotherapy, Conformal (22) · Fluorouracil (19) · Temozolomide (14) · Brachytherapy (12) · Carboplatin (12) · Filgrastim (11) · Flutamide (11) · Gemcitabine (9) · Gonadotropin-Releasing Hormone (9) · Radiosurgery (9) · bicalutamide (9)
United States (173) · Canada (113) · Israel (14) · South Africa (8) · Hong Kong (7) · South Korea (7) · Switzerland (5) · Australia (4) · China (4) · Saudi Arabia (4) · Singapore (4) · Belgium (3) · Ireland (3) · Netherlands (3) · France (2)
Jaffer A. Ajani, MD (5) · Elizabeth M. Gore, MD (4) · Jeffrey Bradley, MD (4) · Al B. Benson, MD, FACP (3) · Benjamin Movsas, MD (3) · Burton L. Eisenberg, MD (3) · Corey J. Langer, MD (3) · Lawrence B. Berk, MD, PhD (3) · Michael G. Haddock, MD (3) · Minesh P. Mehta, MD (3) · Mitchell Machtay, MD (3) · Oliver Sartor, MD (3) · Ritsuko U. Komaki, MD, FACR (3) · Robert D. Timmerman, MD (3) · Timothy J. Whelan, MD (3)
PMID 38320143, PMID 31420360, PMID 36596347, PMID 41343184, PMID 25366678, PMID 30548235, PMID 36884035, PMID 36995690, PMID 37751207, PMID 10661346, PMID 10924966, PMID 11560968, PMID 11586105, PMID 11870157, PMID 11917283, PMID 12499279, PMID 12525193, PMID 12694838, PMID 12743142, PMID 12788192, PMID 14508838, PMID 14529764, PMID 14529772, PMID 14581419, PMID 14645636, PMID 14758134, PMID 14967428, PMID 15050309, PMID 15128893, PMID 15158627, PMID 15169799, PMID 15234047, PMID 15465203, PMID 15590164, PMID 15667949, PMID 15735120, PMID 15764775, PMID 15800308, PMID 15860857, PMID 15863167, PMID 15890570, PMID 15890573, PMID 15928300, PMID 15936549, PMID 15989995, PMID 16015544, PMID 16062084, PMID 16167048, PMID 16198508, PMID 16287132
U10CA021661 (18), U10CA180868 (7), U10CA032102 (3), 2015 (1), U10CA012027 (1), U10CA021115 (1), U10CA031946 (1), U10CA037422 (1), U10CA045809 (1), U10CA077202 (1), UG1CA189867 (1)